Meridian Management CO Bristol Myers Squibb CO Transaction History

Meridian Management CO

$358 Million
Q1 2024

A detailed history of Meridian Management CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Meridian Management CO holds 28,069 shares of BMY stock, worth $1.12 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

28,069

Previous 28,124 0.2%

Holding current value

$1.12 Million

Previous $1.44 Million 5.47%

% of portfolio

0.42%

Previous 0.42%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$47.98 - $54.4 $2,638 - $2,992	-55 Reduced 0.2%	28,069 $1.52 Million
Q4 2023 Feb 12, 2024	BUY	$48.48 - $57.85 $12,265 - $14,636	253 Added 0.91%	28,124 $1.44 Million
Q3 2023 Nov 03, 2023	SELL	$57.89 - $64.73 $1.2 Million - $1.35 Million	-20,810 Reduced 42.75%	27,871 $1.62 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $1,465 - $1,627	-23 Reduced 0.05%	48,681 $3.11 Million
Q1 2023 May 02, 2023	BUY	$65.71 - $74.53 $798,573 - $905,763	12,153 Added 33.25%	48,704 $3.38 Million

Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $1.51 Million - $1.79 Million	22,086 Added 152.69%	36,551 $2.63 Million
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $37,762 - $41,589	-520 Reduced 3.47%	14,465 $1.11 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $3.23 Million - $3.77 Million	-60,287 Reduced 80.09%	14,985 $934,000
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $13,313 - $15,594	225 Added 0.3%	75,272 $4.45 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $3.72 Million - $4.06 Million	60,160 Added 404.11%	75,047 $5.02 Million
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $6,527 - $7,341	110 Added 0.74%	14,887 $940,000
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $204,160 - $296,692	-4,400 Reduced 22.94%	14,777 $824,000
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $434,868 - $567,247	8,837 Added 85.46%	19,177 $1.23 Million
Q3 2019 Nov 06, 2019	BUY	$42.77 - $50.71 $12,831 - $15,213	300 Added 2.99%	10,340 $524,000
Q2 2018 Aug 03, 2018	SELL	$50.53 - $62.98 $2.07 Million - $2.58 Million	-40,955 Reduced 80.31%	10,040 $556,000
Q1 2018 May 08, 2018	SELL	$59.92 - $68.98 $2,097 - $2,414	-35 Reduced 0.07%	50,995 $3.23 Million
Q4 2017 Feb 05, 2018	SELL	$59.94 - $65.35 $9,290 - $10,129	-155 Reduced 0.3%	51,030 $3.13 Million
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $2.83 Million - $3.26 Million	51,185	51,185 $0

Others Institutions Holding BMY

# of Institutions

2,555

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $85B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Management CO with notifications on news.

Account

Meridian Management CO Bristol Myers Squibb CO Transaction History